Dalbøge, L.S.; Christensen, M.; Madsen, M.R.; Secher, T.; Endlich, N.; Drenic’, V.; Manresa-Arraut, A.; Hansen, H.H.; Rune, I.; Fink, L.N.;
et al. Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease. Biomedicines 2022, 10, 1661.
https://doi.org/10.3390/biomedicines10071661
AMA Style
Dalbøge LS, Christensen M, Madsen MR, Secher T, Endlich N, Drenic’ V, Manresa-Arraut A, Hansen HH, Rune I, Fink LN,
et al. Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease. Biomedicines. 2022; 10(7):1661.
https://doi.org/10.3390/biomedicines10071661
Chicago/Turabian Style
Dalbøge, Louise S., Michael Christensen, Martin Rønn Madsen, Thomas Secher, Nicole Endlich, Vedran Drenic’, Alba Manresa-Arraut, Henrik H. Hansen, Ida Rune, Lisbeth N. Fink,
and et al. 2022. "Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease" Biomedicines 10, no. 7: 1661.
https://doi.org/10.3390/biomedicines10071661
APA Style
Dalbøge, L. S., Christensen, M., Madsen, M. R., Secher, T., Endlich, N., Drenic’, V., Manresa-Arraut, A., Hansen, H. H., Rune, I., Fink, L. N., & Østergaard, M. V.
(2022). Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease. Biomedicines, 10(7), 1661.
https://doi.org/10.3390/biomedicines10071661